Zobrazeno 1 - 10
of 166
pro vyhledávání: '"Burton I, Korelitz"'
Autor:
Keith, Sultan, Laura, Durbin, Richa, Bhardwaj, James, Mackey, Noah, Becher, Mohammad, Abureesh, Komal, Lakhani, Anjali, Mone, Jeffrey, Abergel, Arvind, Trindade, Burton I, Korelitz, Arun, Swaminath
Publikováno v:
Gastroenterology Research
Background To date, studies investigating the inflammatory bowel disease (IBD) patient experience with coronavirus disease 2019 (COVID-19) have consistently reported that the observed rate of COVID-19 within this population is similar to the general
Autor:
Judy Schneider, Burton I. Korelitz
Publikováno v:
Crohn's & Colitis 360. 3
We present a bird’s eye view of the prognosis for both ulcerative colitis and Crohn disease as contained in the database of an Inflammatory Bowel Disease gastroenterologist covering the period from 1950 until the present utilizing the variables of
Autor:
Mitchell Roslin, Jeffrey S. Aronoff, Judy Schneider, Burton I. Korelitz, Arun Swaminath, Joseph B. Felder, Niket Sonpal
Publikováno v:
Journal of Clinical Gastroenterology. 52:50-54
Background Crohn's disease (CD) following bariatric surgery has been previously described. It is not clear whether the clinical entity is due to rapid metabolism of fat, change in the bacterial milieu of the bowel, the loss of defense mechanisms of t
Publikováno v:
American Journal of Gastroenterology. 115:2109-2110
Autor:
Bo Shen, Burton I. Korelitz, Guillaume Stoffels, Ahmed M. Al-Mazrou, David Dicaprio, Ravi P. Kiran, Steven A. Lee-Kong, Arun Swaminath
Publikováno v:
International journal of colorectal disease. 33(11)
Patients with ulcerative colitis, a high-risk group for the development of colon cancer, undergo colonoscopy more frequently than the general population. This increase in endoscopic evaluation also exposes these patients to an increased risk of compl
Autor:
Guillaume Stoffels, Arun Swaminath, Burton I. Korelitz, Kelly Teagle, Judy Schneider, Martin Ellington, Bernard Partiula
Publikováno v:
Inflammatory intestinal diseases. 3(1)
Objective: To seek the habits of pediatricians by which anorectal skin tags (AST) of Crohn’s disease might be overlooked. Methods: Questionnaires were sent to pediatricians affiliated with the Northwell Health System. Results: Based on the response
Autor:
Brian G. Feagan, Mark R. Fleisher, Laura E. Frado, Alyssa Parian, Burton I. Korelitz, Jan Marsal, Scott D. Lee
Publikováno v:
Digestive Diseases and Sciences
Background Approximately 15–20% of ulcerative colitis patients and 20–40% of those with Crohn’s disease experience extraintestinal manifestations (EIMs) of their inflammatory bowel disease (IBD). Clinicians who treat IBD must manage EIMs affect
Is Treatment with 6-Mercaptopurine for Colitis Associated with the Development of Colorectal Cancer?
Autor:
Mylan Satchi, Georgia Panagopoulos, Christine Yu, Burton I. Korelitz, Judy Schneider, Jean Atallah-Vinograd, Jason Bratcher
Publikováno v:
Inflammatory Bowel Diseases. 19:785-788
Background Patients with ulcerative colitis and Crohn's colitis have an increased risk of colon cancer influenced by the duration, extent, and severity of disease. Surveillance colonoscopy serves to detect cancer and precancerous dysplasia at the ear
Publikováno v:
Journal of clinical gastroenterology. 51(7)
Background We have previously recognized segmental sigmoid polyps as an indicator of a fistula from Crohn's ileitis to the sigmoid or the proximal rectum. In the course of this study, we realized that many patients with this fistula had no sigmoid po
Autor:
Keith Sultan, Iuliana Shapira, Suzanne Sunday, Daniel Present, Seymour Katz, Burton I. Korelitz
Publikováno v:
Inflammatory Bowel Diseases. 18:1855-1858
Background: 6-Mercaptopurine (6-MP) and azathioprine (AZA) are effective for induction and maintenance therapy of Crohn's disease (CD) and ulcerative colitis (UC). There is an increased risk of lymphoma in patients with inflammatory bowel disease (IB